Premium
Tenascin C induces a quiescent phenotype in cultured adult human astrocytes
Author(s) -
Holley Janet E.,
Gveric Djordje,
Whatmore Jacqueline L.,
Gutowski Nicholas J.
Publication year - 2005
Publication title -
glia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.954
H-Index - 164
eISSN - 1098-1136
pISSN - 0894-1491
DOI - 10.1002/glia.20231
Subject(s) - astrogliosis , astrocyte , glial scar , biology , tenascin , extracellular matrix , tenascin c , microbiology and biotechnology , phenotype , neuroglia , glial fibrillary acidic protein , neuroscience , immunology , central nervous system , biochemistry , fibronectin , immunohistochemistry , gene
Astrocytic scar formation occurs subsequent to brain and spinal cord injury and impedes repair. The exact mechanisms of scar formation have yet to be elucidated but it is known that astrocytes within the scar have a different antigenic phenotype from normal or reactive astrocytes. Astrocyte cell culture offers a suitable system to identify factors that induce the scar phenotype as well as factors that reverse this process and that may help identify therapeutic strategies to treat astrogliosis. However, when placed in standard culture conditions, astrocytes become activated/reactive and express molecules characteristic of scar tissue in vivo . In the present study, we made use of this phenomenon to identify culture conditions that change the activated phenotype of cultured astrocytes into one characteristic of normal quiescent astrocytes. In particular, we examined the effect of extracellular matrix (ECM) proteins found in the human brain, on the phenotype of human adult astrocytes. Significantly fewer astrocytes expressed scar properties when grown on tenascin‐C (TN‐C) than those cultured on other ECM proteins or poly‐ L ‐lysine‐coated dishes. TN‐C also significantly reduced the proliferation rate of the astrocytes in vitro . In addition, further manipulation of culture conditions induced partial astrocyte reactivation. Our findings suggest that astrocytes grown on TN‐C revert to a quiescent, nonactivated state that is partially reversible. This raises the possibility that therapeutic strategies aimed at manipulating TN‐C levels during CNS injury may help reduce astrocytic scarring. © 2005 Wiley‐Liss, Inc.